0

Close
 
Upcoming Allied Market Research
2023
Aquaculture Vaccines Market

Aquaculture Vaccines Market: Global Opportunity Analysis and Industry Forecast 2019-2027 Market

LS : Diagnostics and Biotech
Report Code: A10284
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Aquaculture Vaccines Market

Request Now !

A vaccine is a substance that is intended to establish or improve the consumers’ immunity towards a disease. Vaccines have been used in humans, companion animals, and terrestrial livestock against a variety of diseases.

Aquaculture Vaccines Market

Disease is the biggest challenge in the aquaculture field. General management and favorable husbandry comprises of immunity, genetics, system management, nutrition, and water quality are the most important factors to enlarge the aquatic animal healthcare. The perfect vaccine should be secure enough for the fish, the person(s) vaccinating the fish, as well as for the end-user and it also protects against various pathogens and also helps protect against any disease. It also delivers enduring protection for the complete life cycle. These vaccines are manufactured in such a way that the application is easier and can be applied to various fish species simultaneously. These vaccines also need to be at an optimal cost and should be approved and registered in the FDA.

COVID-19 scenario analysis:

The coronavirus pandemic is having a huge impact on businesses and has already caused an unprecedented collapse of economic activities. The COVID-19 impact is straining the healthcare systems globally. The rapidly increasing demand for healthcare facilities and healthcare workers may leave only a few healthcare systems to fulfill the increasing demand during the pandemic situation. 

The COVID-19 pandemic cases are because of direct or indirect contact between humans. There has been no evidence or confirmation that animals can spread COVID-19 to humans. The myth animals can spread the virus to humans has increased the number of abandoned pets. Furthermore, COVID-19 has weakened the supply chain and has created a shortage of animal health products such as nutritional feed as well as vaccines globally. The animal health industry has been impacted largely as many manufacturers in the animal health industry are left with a significantly reduced workforce. Also, stringent government policies such as restrictions of import of raw materials from China are expected to hamper the animal health market.

Healthcare facilities are stocking up the animal-related health products, considering the high demand. This is expected to further create a financial strain on the market due to procurement inefficiencies and wasted speeding. Due to the pandemic situation, many hospitals and veterinary clinics are overstocking the products.

Owing to such factors, COVID 19 is expected to have a significant impact on the aquaculture vaccines market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Improvement in the quality of vaccines by aquaculture breeders, appropriate guidelines, and restriction over the use of these vaccines laid by the nations are helping improve the selection and application of aquaculture vaccines. Moreover, the improvement of vaccines for aquaculture is growing the market positively. New and fast-growing vaccination research to cure virus and bacteria related diseases are expected to drive the market development. Manufacturers are now focusing on the transmission and development of the vaccines. Various research programs for the development of vaccines are expected to drive the market further.

On the other hand, strict policies and regulations required for the vaccines to enter the market is a challenge for the aquaculture market. Moreover, the development process of the vaccines is far more complex and time-consuming which is hampering the growth of the market.

New product launches and acquisitions to flourish the market:

On December 6th, 2018, Phibro Animal Health Corporation was acquired by KoVax Ltd. Phibro with the help of KoVax entered in the aquaculture vaccines market and it helped strengthen Phibro’s position in the fish vaccine innovations market.

On June 16th, 2016, Norwegian fish health firm PharmaQ ran a test on its live salmon rickettsial septicemia (SRS) vaccine on 20 million young Chilean fish, which was already approved.

On January 3rd, 2017, PharmaQ acquired Nordland Sett Vaks which helped them strengthen their fish vaccine portfolio.

Surge in usage in hospital applications:

There are various distributors, online stores, retail, and aqua stores who sell aquaculture vaccines. Online pharmacies are the biggest consumers among them. A large variety of vaccines have been catered for various diseases in aquatic animals which are helping in contributing to the demand. Moreover, there is considerable growth in online shopping. These factors will boost the online stores and are contributing to the market expansion.

Key benefits of the report:

  • This study presents the analytical depiction of the global Aquaculture vaccines industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Aquaculture vaccines market share.
  • The current market is quantitatively analyzed to highlight the global Aquaculture vaccines market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Aquaculture vaccines market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Aquaculture vaccines Market research report:

  • What are the leading market players active in the Aquaculture vaccines market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

 Aquaculture Vaccines Market: Global Opportunity Analysis and Industry Forecast 2019–2027 Report Highlights

Aspects Details
By Type
  • Live Vaccines
  • Inactivated Vaccines
  • Other Vaccines
By Route of Administration
  • Injection Vaccines
  • Immersions Vaccines
  • Oral Vaccines
By Application
  • Viral Infection
  • Bacterial Infection
  • Others
By Species
  • Tilapia
  • Trout
  • Salmon
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Zoetis Inc., Tecnovax SA, Hipra, Nisseiken Co. Ltd., Tecnovax, Merck and Co. Inc., Virbac, KoVax Ltd, Elanco, Veterquimica S.A
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: AQUACULTURE VACCINES MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Live Vaccines

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Inactivated Vaccines

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Other Vaccines

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: AQUACULTURE VACCINES MARKET, BY ROUTE OF ADMINISTRATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Route Of Administration

    • 5.2. Injection Vaccines

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Immersions Vaccines

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Oral Vaccines

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: AQUACULTURE VACCINES MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Viral Infection

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Bacterial Infection

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Others

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: AQUACULTURE VACCINES MARKET, BY SPECIES

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Species

    • 7.2. Tilapia

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Trout

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Salmon

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Others

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

  • CHAPTER 8: AQUACULTURE VACCINES MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Type

      • 8.2.3. Market Size and Forecast, By Route Of Administration

      • 8.2.4. Market Size and Forecast, By Application

      • 8.2.5. Market Size and Forecast, By Species

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Aquaculture Vaccines Market

        • 8.2.7.1. Market Size and Forecast, By Type
        • 8.2.7.2. Market Size and Forecast, By Route Of Administration
        • 8.2.7.3. Market Size and Forecast, By Application
        • 8.2.7.4. Market Size and Forecast, By Species

      • 8.2.8. Canada Aquaculture Vaccines Market

        • 8.2.8.1. Market Size and Forecast, By Type
        • 8.2.8.2. Market Size and Forecast, By Route Of Administration
        • 8.2.8.3. Market Size and Forecast, By Application
        • 8.2.8.4. Market Size and Forecast, By Species

      • 8.2.9. Mexico Aquaculture Vaccines Market

        • 8.2.9.1. Market Size and Forecast, By Type
        • 8.2.9.2. Market Size and Forecast, By Route Of Administration
        • 8.2.9.3. Market Size and Forecast, By Application
        • 8.2.9.4. Market Size and Forecast, By Species

    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Type

      • 8.3.3. Market Size and Forecast, By Route Of Administration

      • 8.3.4. Market Size and Forecast, By Application

      • 8.3.5. Market Size and Forecast, By Species

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Aquaculture Vaccines Market

        • 8.3.7.1. Market Size and Forecast, By Type
        • 8.3.7.2. Market Size and Forecast, By Route Of Administration
        • 8.3.7.3. Market Size and Forecast, By Application
        • 8.3.7.4. Market Size and Forecast, By Species

      • 8.3.8. Germany Aquaculture Vaccines Market

        • 8.3.8.1. Market Size and Forecast, By Type
        • 8.3.8.2. Market Size and Forecast, By Route Of Administration
        • 8.3.8.3. Market Size and Forecast, By Application
        • 8.3.8.4. Market Size and Forecast, By Species

      • 8.3.9. Italy Aquaculture Vaccines Market

        • 8.3.9.1. Market Size and Forecast, By Type
        • 8.3.9.2. Market Size and Forecast, By Route Of Administration
        • 8.3.9.3. Market Size and Forecast, By Application
        • 8.3.9.4. Market Size and Forecast, By Species

      • 8.3.10. Spain Aquaculture Vaccines Market

        • 8.3.10.1. Market Size and Forecast, By Type
        • 8.3.10.2. Market Size and Forecast, By Route Of Administration
        • 8.3.10.3. Market Size and Forecast, By Application
        • 8.3.10.4. Market Size and Forecast, By Species

      • 8.3.11. UK Aquaculture Vaccines Market

        • 8.3.11.1. Market Size and Forecast, By Type
        • 8.3.11.2. Market Size and Forecast, By Route Of Administration
        • 8.3.11.3. Market Size and Forecast, By Application
        • 8.3.11.4. Market Size and Forecast, By Species

      • 8.3.12. Russia Aquaculture Vaccines Market

        • 8.3.12.1. Market Size and Forecast, By Type
        • 8.3.12.2. Market Size and Forecast, By Route Of Administration
        • 8.3.12.3. Market Size and Forecast, By Application
        • 8.3.12.4. Market Size and Forecast, By Species

      • 8.3.13. Rest Of Europe Aquaculture Vaccines Market

        • 8.3.13.1. Market Size and Forecast, By Type
        • 8.3.13.2. Market Size and Forecast, By Route Of Administration
        • 8.3.13.3. Market Size and Forecast, By Application
        • 8.3.13.4. Market Size and Forecast, By Species

    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Type

      • 8.4.3. Market Size and Forecast, By Route Of Administration

      • 8.4.4. Market Size and Forecast, By Application

      • 8.4.5. Market Size and Forecast, By Species

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Aquaculture Vaccines Market

        • 8.4.7.1. Market Size and Forecast, By Type
        • 8.4.7.2. Market Size and Forecast, By Route Of Administration
        • 8.4.7.3. Market Size and Forecast, By Application
        • 8.4.7.4. Market Size and Forecast, By Species

      • 8.4.8. Japan Aquaculture Vaccines Market

        • 8.4.8.1. Market Size and Forecast, By Type
        • 8.4.8.2. Market Size and Forecast, By Route Of Administration
        • 8.4.8.3. Market Size and Forecast, By Application
        • 8.4.8.4. Market Size and Forecast, By Species

      • 8.4.9. India Aquaculture Vaccines Market

        • 8.4.9.1. Market Size and Forecast, By Type
        • 8.4.9.2. Market Size and Forecast, By Route Of Administration
        • 8.4.9.3. Market Size and Forecast, By Application
        • 8.4.9.4. Market Size and Forecast, By Species

      • 8.4.10. South Korea Aquaculture Vaccines Market

        • 8.4.10.1. Market Size and Forecast, By Type
        • 8.4.10.2. Market Size and Forecast, By Route Of Administration
        • 8.4.10.3. Market Size and Forecast, By Application
        • 8.4.10.4. Market Size and Forecast, By Species

      • 8.4.11. Australia Aquaculture Vaccines Market

        • 8.4.11.1. Market Size and Forecast, By Type
        • 8.4.11.2. Market Size and Forecast, By Route Of Administration
        • 8.4.11.3. Market Size and Forecast, By Application
        • 8.4.11.4. Market Size and Forecast, By Species

      • 8.4.12. Thailand Aquaculture Vaccines Market

        • 8.4.12.1. Market Size and Forecast, By Type
        • 8.4.12.2. Market Size and Forecast, By Route Of Administration
        • 8.4.12.3. Market Size and Forecast, By Application
        • 8.4.12.4. Market Size and Forecast, By Species

      • 8.4.13. Malaysia Aquaculture Vaccines Market

        • 8.4.13.1. Market Size and Forecast, By Type
        • 8.4.13.2. Market Size and Forecast, By Route Of Administration
        • 8.4.13.3. Market Size and Forecast, By Application
        • 8.4.13.4. Market Size and Forecast, By Species

      • 8.4.14. Indonesia Aquaculture Vaccines Market

        • 8.4.14.1. Market Size and Forecast, By Type
        • 8.4.14.2. Market Size and Forecast, By Route Of Administration
        • 8.4.14.3. Market Size and Forecast, By Application
        • 8.4.14.4. Market Size and Forecast, By Species

      • 8.4.15. Rest of Asia Pacific Aquaculture Vaccines Market

        • 8.4.15.1. Market Size and Forecast, By Type
        • 8.4.15.2. Market Size and Forecast, By Route Of Administration
        • 8.4.15.3. Market Size and Forecast, By Application
        • 8.4.15.4. Market Size and Forecast, By Species

    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Type

      • 8.5.3. Market Size and Forecast, By Route Of Administration

      • 8.5.4. Market Size and Forecast, By Application

      • 8.5.5. Market Size and Forecast, By Species

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Aquaculture Vaccines Market

        • 8.5.7.1. Market Size and Forecast, By Type
        • 8.5.7.2. Market Size and Forecast, By Route Of Administration
        • 8.5.7.3. Market Size and Forecast, By Application
        • 8.5.7.4. Market Size and Forecast, By Species

      • 8.5.8. South Africa Aquaculture Vaccines Market

        • 8.5.8.1. Market Size and Forecast, By Type
        • 8.5.8.2. Market Size and Forecast, By Route Of Administration
        • 8.5.8.3. Market Size and Forecast, By Application
        • 8.5.8.4. Market Size and Forecast, By Species

      • 8.5.9. Saudi Arabia Aquaculture Vaccines Market

        • 8.5.9.1. Market Size and Forecast, By Type
        • 8.5.9.2. Market Size and Forecast, By Route Of Administration
        • 8.5.9.3. Market Size and Forecast, By Application
        • 8.5.9.4. Market Size and Forecast, By Species

      • 8.5.10. UAE Aquaculture Vaccines Market

        • 8.5.10.1. Market Size and Forecast, By Type
        • 8.5.10.2. Market Size and Forecast, By Route Of Administration
        • 8.5.10.3. Market Size and Forecast, By Application
        • 8.5.10.4. Market Size and Forecast, By Species

      • 8.5.11. Argentina Aquaculture Vaccines Market

        • 8.5.11.1. Market Size and Forecast, By Type
        • 8.5.11.2. Market Size and Forecast, By Route Of Administration
        • 8.5.11.3. Market Size and Forecast, By Application
        • 8.5.11.4. Market Size and Forecast, By Species

      • 8.5.12. Rest of LAMEA Aquaculture Vaccines Market

        • 8.5.12.1. Market Size and Forecast, By Type
        • 8.5.12.2. Market Size and Forecast, By Route Of Administration
        • 8.5.12.3. Market Size and Forecast, By Application
        • 8.5.12.4. Market Size and Forecast, By Species

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Zoetis Inc.

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Veterquimica S.A

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Hipra

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Tecnovax

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Merck And Co. Inc.

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Virbac

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Nisseiken Co. Ltd.

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. KoVax Ltd

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Tecnovax SA

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Elanco

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL AQUACULTURE VACCINES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL AQUACULTURE VACCINES MARKET FOR LIVE VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL AQUACULTURE VACCINES MARKET FOR INACTIVATED VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL AQUACULTURE VACCINES MARKET FOR OTHER VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL AQUACULTURE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL AQUACULTURE VACCINES MARKET FOR INJECTION VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL AQUACULTURE VACCINES MARKET FOR IMMERSIONS VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL AQUACULTURE VACCINES MARKET FOR ORAL VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL AQUACULTURE VACCINES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL AQUACULTURE VACCINES MARKET FOR VIRAL INFECTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL AQUACULTURE VACCINES MARKET FOR BACTERIAL INFECTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL AQUACULTURE VACCINES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL AQUACULTURE VACCINES MARKET, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL AQUACULTURE VACCINES MARKET FOR TILAPIA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL AQUACULTURE VACCINES MARKET FOR TROUT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL AQUACULTURE VACCINES MARKET FOR SALMON, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL AQUACULTURE VACCINES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL AQUACULTURE VACCINES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA AQUACULTURE VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 24. U.S. AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. U.S. AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 26. U.S. AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. U.S. AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 28. CANADA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 29. CANADA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 30. CANADA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. CANADA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE AQUACULTURE VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 41. FRANCE AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 43. FRANCE AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. FRANCE AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 45. GERMANY AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 46. GERMANY AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 47. GERMANY AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 49. ITALY AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. ITALY AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 51. ITALY AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. ITALY AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 53. SPAIN AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. SPAIN AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 55. SPAIN AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 56. SPAIN AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 57. UK AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. UK AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 59. UK AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. UK AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 61. RUSSIA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. RUSSIA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 63. RUSSIA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. RUSSIA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 65. REST OF EUROPE AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. REST OF EUROPE AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 67. REST OF EUROPE AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. REST OF EUROPE AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 69. ASIA-PACIFIC AQUACULTURE VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 70. ASIA-PACIFIC AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 71. ASIA-PACIFIC AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 72. ASIA-PACIFIC AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. ASIA-PACIFIC AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 74. CHINA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 75. CHINA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 76. CHINA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. CHINA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 78. JAPAN AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 79. JAPAN AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 80. JAPAN AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 81. JAPAN AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 82. INDIA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 83. INDIA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 84. INDIA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 85. INDIA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH KOREA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH KOREA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH KOREA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 90. AUSTRALIA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 91. AUSTRALIA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 92. AUSTRALIA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 93. AUSTRALIA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 94. THAILAND AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 95. THAILAND AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 96. THAILAND AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 97. THAILAND AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 98. MALAYSIA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 99. MALAYSIA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 100. MALAYSIA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 101. MALAYSIA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 102. INDONESIA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 103. INDONESIA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 104. INDONESIA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 105. INDONESIA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 106. REST OF ASIA PACIFIC AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 107. REST OF ASIA PACIFIC AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 108. REST OF ASIA PACIFIC AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 110. LAMEA AQUACULTURE VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 111. LAMEA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 112. LAMEA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 113. LAMEA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 114. LAMEA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 115. BRAZIL AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 116. BRAZIL AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 117. BRAZIL AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 118. BRAZIL AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 119. SOUTH AFRICA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 120. SOUTH AFRICA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 121. SOUTH AFRICA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 122. SOUTH AFRICA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 123. SAUDI ARABIA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 124. SAUDI ARABIA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 125. SAUDI ARABIA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 126. SAUDI ARABIA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 127. UAE AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 128. UAE AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 129. UAE AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 130. UAE AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 131. ARGENTINA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 132. ARGENTINA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 133. ARGENTINA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 134. ARGENTINA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 135. REST OF LAMEA AQUACULTURE VACCINES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 136. REST OF LAMEA AQUACULTURE VACCINES, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
  • TABLE 137. REST OF LAMEA AQUACULTURE VACCINES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 138. REST OF LAMEA AQUACULTURE VACCINES, BY SPECIES, 2022-2032 ($MILLION)
  • TABLE 139. ZOETIS INC.: KEY EXECUTIVES
  • TABLE 140. ZOETIS INC.: COMPANY SNAPSHOT
  • TABLE 141. ZOETIS INC.: OPERATING SEGMENTS
  • TABLE 142. ZOETIS INC.: PRODUCT PORTFOLIO
  • TABLE 143. ZOETIS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. VETERQUIMICA S.A: KEY EXECUTIVES
  • TABLE 145. VETERQUIMICA S.A: COMPANY SNAPSHOT
  • TABLE 146. VETERQUIMICA S.A: OPERATING SEGMENTS
  • TABLE 147. VETERQUIMICA S.A: PRODUCT PORTFOLIO
  • TABLE 148. VETERQUIMICA S.A: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. HIPRA: KEY EXECUTIVES
  • TABLE 150. HIPRA: COMPANY SNAPSHOT
  • TABLE 151. HIPRA: OPERATING SEGMENTS
  • TABLE 152. HIPRA: PRODUCT PORTFOLIO
  • TABLE 153. HIPRA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. TECNOVAX: KEY EXECUTIVES
  • TABLE 155. TECNOVAX: COMPANY SNAPSHOT
  • TABLE 156. TECNOVAX: OPERATING SEGMENTS
  • TABLE 157. TECNOVAX: PRODUCT PORTFOLIO
  • TABLE 158. TECNOVAX: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 159. MERCK AND CO. INC.: KEY EXECUTIVES
  • TABLE 160. MERCK AND CO. INC.: COMPANY SNAPSHOT
  • TABLE 161. MERCK AND CO. INC.: OPERATING SEGMENTS
  • TABLE 162. MERCK AND CO. INC.: PRODUCT PORTFOLIO
  • TABLE 163. MERCK AND CO. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 164. VIRBAC: KEY EXECUTIVES
  • TABLE 165. VIRBAC: COMPANY SNAPSHOT
  • TABLE 166. VIRBAC: OPERATING SEGMENTS
  • TABLE 167. VIRBAC: PRODUCT PORTFOLIO
  • TABLE 168. VIRBAC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 169. NISSEIKEN CO. LTD.: KEY EXECUTIVES
  • TABLE 170. NISSEIKEN CO. LTD.: COMPANY SNAPSHOT
  • TABLE 171. NISSEIKEN CO. LTD.: OPERATING SEGMENTS
  • TABLE 172. NISSEIKEN CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 173. NISSEIKEN CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 174. KOVAX LTD: KEY EXECUTIVES
  • TABLE 175. KOVAX LTD: COMPANY SNAPSHOT
  • TABLE 176. KOVAX LTD: OPERATING SEGMENTS
  • TABLE 177. KOVAX LTD: PRODUCT PORTFOLIO
  • TABLE 178. KOVAX LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 179. TECNOVAX SA: KEY EXECUTIVES
  • TABLE 180. TECNOVAX SA: COMPANY SNAPSHOT
  • TABLE 181. TECNOVAX SA: OPERATING SEGMENTS
  • TABLE 182. TECNOVAX SA: PRODUCT PORTFOLIO
  • TABLE 183. TECNOVAX SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 184. ELANCO: KEY EXECUTIVES
  • TABLE 185. ELANCO: COMPANY SNAPSHOT
  • TABLE 186. ELANCO: OPERATING SEGMENTS
  • TABLE 187. ELANCO: PRODUCT PORTFOLIO
  • TABLE 188. ELANCO: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL AQUACULTURE VACCINES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL AQUACULTURE VACCINES MARKET
  • FIGURE 3. SEGMENTATION AQUACULTURE VACCINES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN AQUACULTURE VACCINES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALAQUACULTURE VACCINES MARKET
  • FIGURE 11. AQUACULTURE VACCINES MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. AQUACULTURE VACCINES MARKET FOR LIVE VACCINES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. AQUACULTURE VACCINES MARKET FOR INACTIVATED VACCINES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. AQUACULTURE VACCINES MARKET FOR OTHER VACCINES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. AQUACULTURE VACCINES MARKET SEGMENTATION, BY BY ROUTE OF ADMINISTRATION
  • FIGURE 16. AQUACULTURE VACCINES MARKET FOR INJECTION VACCINES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. AQUACULTURE VACCINES MARKET FOR IMMERSIONS VACCINES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. AQUACULTURE VACCINES MARKET FOR ORAL VACCINES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. AQUACULTURE VACCINES MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 20. AQUACULTURE VACCINES MARKET FOR VIRAL INFECTION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. AQUACULTURE VACCINES MARKET FOR BACTERIAL INFECTION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. AQUACULTURE VACCINES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. AQUACULTURE VACCINES MARKET SEGMENTATION, BY BY SPECIES
  • FIGURE 24. AQUACULTURE VACCINES MARKET FOR TILAPIA, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. AQUACULTURE VACCINES MARKET FOR TROUT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. AQUACULTURE VACCINES MARKET FOR SALMON, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. AQUACULTURE VACCINES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 29. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 30. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 31. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 32. COMPETITIVE DASHBOARD
  • FIGURE 33. COMPETITIVE HEATMAP: AQUACULTURE VACCINES MARKET
  • FIGURE 34. Top player positioning, 2022
  • FIGURE 35. ZOETIS INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. ZOETIS INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. ZOETIS INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. VETERQUIMICA S.A: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. VETERQUIMICA S.A: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. VETERQUIMICA S.A: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. HIPRA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. HIPRA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. HIPRA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. TECNOVAX: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. TECNOVAX: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. TECNOVAX: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. MERCK AND CO. INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. MERCK AND CO. INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. MERCK AND CO. INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. VIRBAC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. VIRBAC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. VIRBAC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. NISSEIKEN CO. LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. NISSEIKEN CO. LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. NISSEIKEN CO. LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. KOVAX LTD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. KOVAX LTD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. KOVAX LTD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 59. TECNOVAX SA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 60. TECNOVAX SA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 61. TECNOVAX SA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 62. ELANCO: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 63. ELANCO: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 64. ELANCO: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Aquaculture Vaccines Market

Start reading.
This Report and over 68,075+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers